Free Account Opening + AMC Free Demat
Loading...

Evoq Remedies IPO vs krishna defence ipo

Comparision between Evoq Remedies IPO and krishna defence ipo.

IPO Details

Evoq Remedies IPO is a SME Book Built Issue IPO proposed to list at BSE SME while krishna defence ipo is a SME Book Built Issue proposed to list at NSE SME.

  Evoq Remedies IPO krishna defence ipo
Logo Evoq Remedies IPO Logo krishna defence ipo Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Book Built Issue
Listing At BSE SME NSE SME
Lead Managers Swastika Investmart Ltd Hem Securities Limited
Registrar Bigshare Services Pvt Ltd Bigshare Services Pvt Ltd
Market Maker Hem Finlease Private Limited
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Evoq Remedies IPO is up to ₹9.72 Cr whereas the issue size of the krishna defence ipo is up to ₹11.89 Cr. The final issue price of Evoq Remedies IPO is ₹27.00 per share and of krishna defence ipo is ₹39.00 per share.

  Evoq Remedies IPO krishna defence ipo
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹37.00 per share
Issue Price (Upper) ₹39.00 per share
Issue Price (Final) ₹27.00 per share ₹39.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 4000 shares 3000 shares
Fresh Issue Size 36,00,000 shares 30,48,000 shares
Fresh Issue Size (Amount) up to ₹9.72 Cr up to ₹11.89 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 36,00,000 shares 30,48,000 shares
Issue Size Total (Amount) up to ₹9.72 Cr up to ₹11.89 Cr

IPO Timetable

Evoq Remedies IPO opens on Mar 17, 2022, while krishna defence ipo opens on Mar 25, 2022. The closing date of Evoq Remedies IPO and krishna defence ipo is Mar 22, 2022, and Mar 29, 2022, respectively.

  Evoq Remedies IPO krishna defence ipo
Anchor Bid Date
Issue Open Mar 17, 2022 Mar 25, 2022
Issue Close Mar 22, 2022 Mar 29, 2022
Basis Of Allotment (Tentative) Mar 25, 2022 Apr 01, 2022
Initiation of Refunds (Tentative) Mar 28, 2022 Apr 04, 2022
Credit of Share (Tentative) Mar 29, 2022 Apr 05, 2022
Listing date (Tentative) Mar 30, 2022 Apr 06, 2022
Anchor Lockin End date 1 Apr 24, 2022 May 01, 2022
Anchor Lockin End date 2 Jun 23, 2022 Jun 30, 2022

Financials

Evoq Remedies IPO P/E ratio is 33.75, as compared to krishna defence ipo P/E ratio of 18.

  Evoq Remedies IPO krishna defence ipo
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (Rs in Lakh)
  10-Feb-22 31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 2660.58 804.63 565.22 214.78
Total Revenue 1056.58 1002.48 907.21 325
Profit After Tax 93.67 71.38 0.03 1.11
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (Rs in Lakhs)
  30-Sep-21 31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 5,804.14 5,620.06 6,141.36 6,599.65
Total Revenue 2,098.20 3,618.84 2,572.37 5,890.85
Profit After Tax 122.11 193.65 74.61 206.44
Promoter Shareholding (Pre-Issue) 99.99% 100%
Promoter Shareholding (Post-Issue) 73.53% 73.38%
P/E Ratio 33.75 18
Market Cap ₹36.72 Cr. ₹44.65 Cr.
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Evoq Remedies IPO retail investors (RII) are offered 17,10,000 shares while in krishna defence ipo retail investors are offered 17,10,000 shares. Qualified institutional buyers (QIB) are offered in Evoq Remedies IPO and 14,43,000 shares in krishna defence ipo.

  Evoq Remedies IPO krishna defence ipo
Anchor Investor Reserveration 8,64,000 shares
Market Maker Reserveration 1,80,000 shares 1,56,000 shares
QIB 14,43,000 shares
NII 17,10,000 shares 4,35,000 shares
RII 17,10,000 shares 10,14,000 shares
Employee
Others
Total 34,20,000 shares 28,92,000 shares

Bids Received (Subscription)

Evoq Remedies IPO subscribed 1.67x in total, whereas krishna defence ipo subscribed 74.84x.

  Evoq Remedies IPO krishna defence ipo
QIB (times) 8.84x
NII (times) 0.30x 159.90x
Big NII (times)
Small NII (times)
RII (times) 3.03x 132.28x
Employee (times)
Other (times)
Total (times) 1.67x 74.84x

Comments

Add a public comment...